Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0001728746-25-000007

Chief Scientific Officer acquired 32,539 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lillie James Woodruff Chief Scientific Officer 2025-10-27 Grant or award +32,539 32,539 D
Derivatives
Lillie James Woodruff Chief Scientific Officer 2025-10-27 Grant or award · Employee Stock Option (right to buy) +132,023 132,023 D
Loading xslF345X05/form4-10282025_041010.xml…